Bloomberg TechnologyValley
Citrini Bets on Life Sciences After Claude AI Drug Study
Life sciences companies stand to gain from a surge in artificial intelligence fueled drug discovery, says Citrini Research after testing Anthropic PBC’s Claude Science.
Read at Bloomberg Technology ↗Related

ValleyEka is worth $1.45B thanks to a physical AI model that has experts raving TechCrunch AI

JapanDeepSeek-V4.1-Flash-1017 の「Opus 超え」を一次情報で読む ― 本当の料金、比較相手、Claude への影響 Zenn (AI)

SiliconOblivion gamer uses Claude AI to boost average FPS gains up to 48%, stutters slashed by 90% Tom's Hardware
